Showing results (1591-1600 of 1,711) with videos related to

Sort By:
Pageof 172
Journal of the American College of Cardiology|November 10, 2021
2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Martha Gulati, Phillip D Levy, et al.
Journal of the American College of Cardiology|November 10, 2021
2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Martha Gulati, Phillip D Levy, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Risk of Bleeding Among Cangrelor-Treated Patients Administered Upstream P2Y12 Inhibitor Therapy: The CAMEO RegistryJennifer Rymer, Brooke Alhanti, Steven Kemp, et al.
Journal of the American College of Cardiology|February 28, 2024
Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular DiseaseAdam N Berman, David W Biery, Stephanie A Besser, et al.
Journal of the American College of Cardiology|July 5, 2023
P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary EventsFelice Gragnano, Davide Cao, Leah Pirondini, et al.
JACC. Heart Failure|August 9, 2023
Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHFBertram Pitt, Deepak L Bhatt, Michael Szarek, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 2, 2022
Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trialMasafumi Ono, Yoshinobu Onuma, Hideyuki Kawashima, et al.
Circulation. Cardiovascular Interventions|November 18, 2017
Culprit Vessel-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With Cardiogenic Shock Complicating ST-Segment-Elevation Myocardial Infarction: A Collaborative Meta-AnalysisDhaval Kolte, Partha Sardar, Sahil Khera, et al.
The New England Journal of Medicine|November 17, 2020
Sotagliflozin in Patients with Diabetes and Chronic Kidney DiseaseDeepak L Bhatt, Michael Szarek, Bertram Pitt, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 21, 2019
Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54Mikael Dellborg, Marc P Bonaca, Robert F Storey, et al.
Pageof 172